Balata H, et al. - Authors sought to develop and validate a simple prognostic scoring system using readily available clinical and pathological variables that could stratify patients according to the risk of death after lung cancer resection, presuming that a new prognostic tool could be developed by using additional pathological variables not accounted for by pathological stage alone coupled with markers of overall fitness. For non-small cell lung cancer (NSCLC), 2-year overall survival following surgery was predicted by the LNC-PATH score. In survivorship clinics, the development of risk-stratified follow-up protocols may be allowed by this. They noted a moderately well performance of this score with an Area Under the Receiver Operating Characteristic curve (AUROC) value of 0.76 and 0.70 in the derivation and validation cohorts respectively.